Clinical Trial Update: Restoring Tissue and Evaluating Novel Treatments for Efficacy in Wounds [Phase 2, Phase 3]

View source ↗

Summary

This update reports the completion of Phase 2 and Phase 3 trials evaluating novel wound therapies for diabetic foot ulcers sponsored by Lavior Pharma Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Snippet

Sponsor: Lavior Pharma Inc. | Conditions: Diabetic Foot Ulcer | Phase 2, Phase 3 | Status: COMPLETED